The UK government has
confirmed a new scheme which will
give patients with life threatening
or seriously debilitating conditions
access to medicines that did not yet
have marketing authorisation.
Medicines and Healthcare
Products Regulatory Agency
(MHRA) ceo Dr Ian Hudson said
the agency was delighted that the
scheme would be launched in April.
Called the Early Access Medicines
Scheme, Hudson said this was
a “major new development” in
medicines policy in the UK.
“The scheme offers a way by
which unlicensed medicines can
be available to patients before
approval of a licence to benefit
public health. It will also enable
companies to gain additional
knowledge and experience of these
medicines in clinical use.”The above article was sent to subscribers in Pharmacy Daily's issue from 18 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Mar 14
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.